Publicacións en colaboración con investigadores/as de Universidad Miguel Hernández de Elche (31)

2026

  1. Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview

    Machine Learning and Knowledge Extraction, Vol. 8, Núm. 1

  2. Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study)

    Clinical Therapeutics

2025

  1. Delay in cardiology consultation after primary care physician referrals in heart failure: Clinical implications

    ESC Heart Failure, Vol. 12, Núm. 1, pp. 573-581

  2. Differential effect of triglycerides on the prognosis of patients with a first versus recurrent acute coronary syndrome

    European Journal of Clinical Investigation, Vol. 55, Núm. 10

  3. Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study

    Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 19, Núm. 9

  4. Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome

    Journal of Clinical Lipidology, Vol. 19, Núm. 4, pp. 827-834

  5. Gender-specific effects of delay in cardiology consultation following primary care physician referral in atrial fibrillation patients: Impact on one-year outcomes

    International Journal of Cardiology, Vol. 422

2024

  1. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264

  2. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

  3. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

2023

  1. Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials

    The American journal of cardiology, Vol. 205, pp. 321-324

  2. Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models

    Nature Communications, Vol. 14, Núm. 1

  3. Sex differences in thermoregulation in mammals: Implications for energy homeostasis

    Frontiers in Endocrinology, Vol. 14

  4. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events

    Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611

  5. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  2. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

  3. The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice

    Diabetologia, Vol. 65, Núm. 3, pp. 490-505

2021

  1. Expression of the cold thermoreceptor TRPM8 in rodent brain thermoregulatory circuits

    Journal of Comparative Neurology, Vol. 529, Núm. 1, pp. 234-256

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712